Profile
Corporate information
Official name
Triangle Pharmaceuticals Incorporated
Registration country
Official name
Triangle Pharmaceuticals Incorporated
Registration country
Investment activity status
Active investor
Company type
Anti-viral and oncology licensing company.Funding
Funding rounds
(4 Dec 2002)
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Gilead Sciences Inc | A biopharmaceutical company that discovers, develops and commercializes therapeutics. | United States |
(31 Dec 1995)
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Venrock Associates | The venture capital arm of the Rockefeller Family. | United States | Initial investment. Round participant. |
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Abbott Laboratories | United States | Initial investment. Round participant. |
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Lumira Capital Investment Management Inc | Canadian healthcare and life sciences venture capital firm. | Canada | Initial investment. Round participant. |
Investor | Profile | Country | Notes | |
---|---|---|---|---|
OrbiMed Advisors LLC | American investment firm focused on making public and private investments in the healthcare and biotechnology industries. | United States |
Cap Table
Current and past shareholders
Investor | Contacts | Round | |
---|---|---|---|
Abbott Laboratories |
+1 (847) 937-6100 |
N/A | |
BayStar Capital |
N/A | ||
Gilead Sciences Inc A biopharmaceutical company that discovers, develops and commercializes therapeutics. |
Acquisition | ||
Lumira Capital Investment Management Inc Canadian healthcare and life sciences venture capital firm. |
+1 (650) 968-2146 |
N/A | |
OrbiMed Advisors LLC American investment firm focused on making public and private investments in the healthcare and biotechnology industries. |
+1 (212) 739-6400 |
N/A | |
SV Health Investors LLP |
N/A (exited) | ||
Venrock Associates The venture capital arm of the Rockefeller Family. |
+1 (617) 995-2000 |
N/A | |
Warburg Pincus LLC Private equity firm |
+1 (212) 878-0600 |
N/A |